The terpene in black pepper that is literally a cannabinoid
Beta-caryophyllene is a dietary cannabinoid
Bottom Line
Beta-caryophyllene — a terpene found in black pepper, cloves, oregano, and cannabis — selectively activates the CB2 cannabinoid receptor, making it the only known dietary cannabinoid and the only terpene confirmed to directly bind a cannabinoid receptor.
Why It Matters
This is the only confirmed example of a terpene directly binding a cannabinoid receptor. It validates a piece of the entourage effect hypothesis at the receptor level, provides a mechanism for dietary modulation of the endocannabinoid system, and opens a new category of non-psychoactive cannabinoid therapeutics.
The Backstory
In 2008, a team led by Jürg Gertsch at ETH Zurich published a three-word title in one of the most prestigious journals in science: "Beta-caryophyllene is a dietary cannabinoid."
Beta-caryophyllene is the spicy, peppery compound in black pepper. It is in cloves, oregano, cinnamon, rosemary, and hops. It is in cannabis, where it is typically one of the most abundant terpenes. It is in food you have eaten today.
And it directly activates a cannabinoid receptor.
This was not a theoretical prediction or an indirect observation. Gertsch showed that beta-caryophyllene binds the CB2 receptor with nanomolar affinity, functions as a full agonist, and reduces inflammation in living animals through this specific mechanism. It is the only terpene confirmed to directly bind a cannabinoid receptor — and it has been in your spice rack the entire time.
The Researcher
Jürg Gertsch's path to cannabinoid pharmacology was unusual. He studied cultural anthropology and neuroscience at the Universidad Central de Venezuela before turning to biochemistry at the Biozentrum Basel and the University of Sussex. His PhD at ETH Zurich was in natural product chemistry — the science of identifying pharmacologically active compounds in plants and other organisms.
This interdisciplinary background shaped his research question. Gertsch was not a cannabis researcher looking for active compounds in the plant. He was a natural products chemist interested in how dietary compounds interact with the endocannabinoid system. His question was broader: are there cannabinoids hiding in everyday food?
The answer turned out to be sitting in the pepper grinder.
After the beta-caryophyllene paper, Gertsch moved to the University of Bern, where he became a full professor and eventually co-founded Synendos Therapeutics — a company developing drugs that target endocannabinoid transport mechanisms. His research program continues to explore the intersection of diet, natural products, and the endocannabinoid system.
The Experiment
Gertsch and his eight co-authors across institutions in Switzerland, Germany, and the United States conducted a systematic investigation with three distinct phases:
The CB2 knockout experiment is what elevates this paper from interesting to definitive. Many compounds reduce inflammation through various mechanisms. Showing that the effect completely vanishes when you remove CB2 from the equation proves that beta-caryophyllene is working through the endocannabinoid system — not through some other anti-inflammatory pathway.
The Numbers
155 nM
binding affinity (Ki) of beta-caryophyllene at the CB2 receptor. For pharmacological context, this is a moderate but clearly functional affinity — well within the range where biological effects occur. It is selective for CB2, meaning it does not activate CB1 (the receptor that produces the cannabis 'high'). At 5 mg/kg given orally, it produced significant anti-inflammatory effects in living mice — but only when CB2 receptors were present.
For comparison, THC binds CB1 with a Ki of roughly 10-40 nM. Beta-caryophyllene's CB2 affinity is lower but still pharmacologically meaningful — and because it is an abundant dietary compound with GRAS status, it is already widely consumed.
Gertsch et al. (2008), PNAS 105(26):9099-9104
Why This Study Matters for Cannabis
Beta-caryophyllene is one of the most abundant terpenes in cannabis. It is the peppery, spicy note in the aroma profile. Our terpene guide identifies it as one of the five most common terpenes across cannabis cultivars.
For the entourage effect debate, Gertsch's finding is the single strongest piece of evidence. When critics point out (correctly) that most cannabis terpenes do not directly activate CB1 or CB2 receptors, beta-caryophyllene is the exception. It is the one terpene for which direct cannabinoid receptor binding is unambiguously proven.
The Black Pepper Connection
One of the most widely repeated pieces of cannabis folk wisdom is that chewing black peppercorns can reduce cannabis-induced anxiety and paranoia. Neil Young famously endorsed this remedy. The mechanism has never been formally tested in humans, but Gertsch's finding provides a plausible pharmacological basis.
Myth vs. Reality
Chewing black pepper helps with cannabis anxiety because of some vague 'calming' property.
Black pepper is one of the richest dietary sources of beta-caryophyllene, which Gertsch proved is a selective CB2 agonist. CB2 activation modulates immune and inflammatory signaling without psychoactive effects. While no controlled trial has tested whether eating black peppercorns during a cannabis anxiety episode reduces symptoms via CB2 activation, the mechanism is pharmacologically plausible. Other compounds in black pepper (like piperine, an endocannabinoid uptake inhibitor) may also contribute.
The Evidence
Beta-caryophyllene binds CB2 at Ki = 155 nM and reduces inflammation via CB2 in mice. Reynoso-Moreno et al. (2017) showed that an endocannabinoid uptake inhibitor from black pepper produces anti-inflammatory effects in mice.
Gertsch et al. (2008); Reynoso-Moreno et al. (2017)
Beyond Cannabis: A Dietary Cannabinoid
The broader significance of this study extends beyond cannabis pharmacology. Gertsch showed that the endocannabinoid system — the body's own cannabinoid signaling network — is modulated by ordinary dietary compounds. You do not need to consume cannabis to engage your CB2 receptors. Every time you eat food seasoned with black pepper, oregano, or cinnamon, you are consuming a CB2 agonist.
This has implications for understanding the endocannabinoid system as a regulatory network that interfaces not just with endogenous signaling molecules but with the chemical environment of the diet. Gertsch later expanded on this idea in a 2017 review proposing that dietary cannabimimetic compounds may have shaped food preferences and metabolic adaptation over evolutionary timescales.
Cite this study
Gertsch, Jürg; Leonti, Marco; Raduner, Stefan; Racz, Ildiko; Chen, Jian-Zhong; Xie, Xiang-Qun; Altmann, Karl-Heinz; Karsak, Meliha; Zimmer, Andreas. (2008). Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0803601105